Cargando…
Reactivating nuclear PTEN to treat CLL
Autores principales: | Bernardi, Rosa, Ghia, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482590/ https://www.ncbi.nlm.nih.gov/pubmed/28473667 http://dx.doi.org/10.18632/oncotarget.17543 |
Ejemplares similares
-
Rituximab mechanisms of action in B-CLL: a new piece of the puzzle
por: Watier, Hervé
Publicado: (2018) -
Augmenting NF-κB in poor-risk CLL: A general paradigm for other cancers?
por: Tuveson, David, et al.
Publicado: (2015) -
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022) -
Genetic profiling of CLL: a ‘TP53 addict' perspective
por: Lodé, L, et al.
Publicado: (2016) -
Poster: CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL
por: Capasso, Antonella, et al.
Publicado: (2022)